Compare TMO & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMO | MDT |
|---|---|---|
| Founded | 1956 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.3B | 131.9B |
| IPO Year | 1996 | 2014 |
| Metric | TMO | MDT |
|---|---|---|
| Price | $453.51 | $76.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 21 |
| Target Price | ★ $636.00 | $108.21 |
| AVG Volume (30 Days) | 2.2M | ★ 9.1M |
| Earning Date | 04-23-2026 | 06-03-2026 |
| Dividend Yield | 0.40% | ★ 3.58% |
| EPS Growth | 7.32 | ★ 30.80 |
| EPS | ★ 4.43 | 2.76 |
| Revenue | $20,918,000,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $6.55 | $8.91 |
| Revenue Next Year | $5.11 | $6.54 |
| P/E Ratio | $101.26 | ★ $28.16 |
| Revenue Growth | ★ 14.47 | 3.62 |
| 52 Week Low | $385.46 | $74.40 |
| 52 Week High | $643.99 | $106.33 |
| Indicator | TMO | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 36.22 |
| Support Level | $435.27 | $74.40 |
| Resistance Level | $502.20 | $89.01 |
| Average True Range (ATR) | 12.35 | 1.64 |
| MACD | 1.12 | 0.37 |
| Stochastic Oscillator | 41.17 | 32.58 |
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.